Egil Molsted Madsen
Directeur Financier/CFO chez Dako Denmark ApS
Profil
Egil Molsted Madsen is currently the Chief Financial Officer at Dako Denmark ApS.
Previously, he held the same position at MT Hojgaard Holding A from 2013 to 2019 and at MT Højgaard A from 2013 to 2019.
He also served as the Chief Financial Officer at Cytologix Corp.
Postes actifs de Egil Molsted Madsen
| Sociétés | Poste | Début |
|---|---|---|
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Directeur Financier/CFO | 27/04/2011 |
Anciens postes connus de Egil Molsted Madsen
| Sociétés | Poste | Fin |
|---|---|---|
MT Højgaard A/S
 MT Højgaard A/S Engineering & ConstructionIndustrial Services MT Højgaard A/S provide building, civil engineering and construction services. It operates through four business areas such as civil works, construction, utility services and refurbishment. The firm serves in the area of constructing roads, bridges, harbours, shell structures, steel structures, prefabricated construction and concrete renovation for the public and private sectors. The company was founded in May 2001 and is headquartered in Soborg, Denmark. | Directeur Financier/CFO | 01/08/2019 |
| MT HØJGAARD HOLDING A/S | Directeur Financier/CFO | 02/01/2019 |
Cytologix Corp.
 Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Directeur Financier/CFO | 18/05/2011 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MT HØJGAARD HOLDING A/S | Consumer Durables |
| Entreprise privées | 3 |
|---|---|
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Commercial Services |
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
MT Højgaard A/S
MT Højgaard A/S Engineering & ConstructionIndustrial Services MT Højgaard A/S provide building, civil engineering and construction services. It operates through four business areas such as civil works, construction, utility services and refurbishment. The firm serves in the area of constructing roads, bridges, harbours, shell structures, steel structures, prefabricated construction and concrete renovation for the public and private sectors. The company was founded in May 2001 and is headquartered in Soborg, Denmark. | Industrial Services |
